Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 7, 2010, Pages 2855-2866

  Shin, Yong Pyo ^a   Park, Ho Jin ^a   Shin, Seo Hwa ^a   Lee, Young Shin ^a   Park, Seungmi ^a   Jo, Sungho ^b   Lee, Yong Ho ^c   Lee, In Hee ^a  

^a Hoseo University   (South Korea)

^b Dankook University   (South Korea)

^c Catholic University of Daegu   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CEFTAZIDIME; CEFTRIAXONE; CHYMOTRYPSIN; HALOCIDIN; HG 1; HG 34; INDOLICIDIN; KHAL; MATRILYSIN; PEXIGANAN ACETATE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; TEICOPLANIN; TRYPSIN; UNCLASSIFIED DRUG; PEPTIDE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; CHEMISTRY; DRUG EFFECTS; METABOLISM;

CHYMOTRYPSIN; HUMANS; MATRIX METALLOPROTEINASE 7; PEPTIDES; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TRYPSIN;

EID: 77953759616     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01790-09     Document Type: Article

References (50)

1. Batista, C. V., A. Scaloni, D. J. Rigden, L. R. Silva, A. Rodrigues Romero, R. Dukor, A. Sebben, F. Talamo, and C. Bloch. 2001. A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta. FEBS Lett. 494:85-89.
2. Brewer, D., and G. Lajoie. 2002. Structure-based design of potent histatin analogues. Biochemistry 41:5526-5536.
3. Campopiano, D. J., D. J. Clarke, N. C. Polfer, P. E. Barran, R. J. Langley, J. R. Govan, A. Maxwell, and J. R. Dorin. 2004. Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity. J. Biol. Chem. 279:48671-48679.
4. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Dalla Serra, M., O. Cirioni, R. M. Vitale, G. Renzone, M. Coraiola, A. Giacometti, C. Potrich, E. Baroni, G. Guella, M. Sanseverino, S. De Luca, G. Scalise, P. Amodeo, and A. Scaloni. 2008. Structural features of distinctin affecting peptide biological and biochemical properties. Biochemistry 47:7888-7899.
6. Dempsey, C. E., S. Ueno, and M. B. Avison. 2003. Enhanced membrane permeabilization and antibacterial activity of a disulfide-dimerized magainin analogue. Biochemistry 42:402-409.
7. Eckert, R., I. Mchardy, D. K. Yarbrough, J. He, F. Qi, M. H. Anderson, and W. Shi. 2007. Stability and activity in sputum of G10KHc, a potent anti-Pseudomonas antimicrobial peptide. Chem. Biol. Drug Des. 70:456-460.
8. Freidinger, R. M. 2003. Design and synthesis of novel bioactive peptides and peptidomimetics. J. Med. Chem. 46:5553-5566.
9. Hamamoto, K., Y. Kida, Y. Zhang, T. Shimizu, and K. Kuwano. 2002. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol. Immunol. 46:741-749.
10. Hancock, R. E. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:156-164.
11. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
12. Harwig, S. S., N. P. Chen, A. S. Park, and R. I. Lehrer. 1993. Purification of cysteine-rich bioactive peptides from leukocytes by continuous acid-ureapolyacrylamide gel electrophoresis. Anal. Biochem. 208:382-386.
13. Hornef, M. W., K. Pütsep, J. Karlsson, E. Refai, and M. Andersson. 2004. Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat. Immunol. 5:836-843.
14. Jacob, L., and M. Zasloff. 1994. Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found. Symp. 186:197-216.
15. Jang, W. S., K. N. Kim, Y. S. Lee, M. H. Nam, and I. H. Lee. 2002. Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. FEBS Lett. 521:81-86.
16. Jang, W. S., C. H. Kim, K. N. Kim, S. Y. Park, J. H. Lee, S. M. Son, and I. H. Lee. 2003. Biological activities of synthetic analogs of halocidin, an antimicrobial peptide from the tunicate Halocynthia aurantium. Antimicrob. Agents Chemother. 47:2481-2486.
17. Jang, W. S., H. K. Kim, K. Y. Lee, S. A. Kim, Y. S. Han, and I. H. Lee. 2006. Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium. FEBS Lett. 580:1490-1496.
18. Jang, W. S., S. C. Lee, Y. S. Lee, Y. P. Shin, K. H. Shin, B. H. Sung, B. S. Kim, S. H. Lee, and I. H. Lee. 2007. Antimicrobial effect of halocidin-derived peptide in a mouse model of Listeria infection. Antimicrob. Agents Chemother. 51:4148-4156.
19. Jenssen, H., P. Hamill, and R. E. Hancock. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511.
20. Latham, P. W. 1999. Therapeutic peptides revisited. Nat. Biotechnol. 17:755-757.
21. Lee, I. H., Y. S. Lee, C. H. Kim, C. R. Kim, T. Hong, L. Menzel, L. M. Boo, J. Pohl, M. A. Sherman, A. Waring, and R. I. Lehrer. 2001. Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. Biochim. Biophys. Acta 1527:141-148.
22. Lehrer, R. I. 2004. Paradise lost and paradigm found. Nat. Immunol. 5:775-776.
23. Levin, M., P. A. Quint, B. Goldstein, P. Barton, J. S. Bradley, S. D. Shemie, T. Yeh, S. S. Kim, D. P. Cafaro, P. J. Scannon, B. P. Giroir, et al. 2000. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet 356:961-967.
24. Levy, O. 2000. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96:2664-2672.
25. López-Boado, Y. S., C. L. Wilson, L. V. Hooper, J. I. Gordon, S. J. Hultgren, and W. C. Parks. 2000. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J. Cell Biol. 148:1305-1315.
26. Loury, D., J. R. Embree, D. A. Steinberg, S. T. Sonis, and J. C. Fiddes. 1999. Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 87:544-551.
27. Marr, A. K., W. J. Gooderham, and R. E. Hancock. 2006. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6:468-472.
28. McPhee, J. B., and R. E. Hancock. 2005. Function and therapeutic potential of host defence peptides. J. Pept. Sci. 11:677-687.
29. Melo, M. N., D. Dugourd, and M. A. Castanho. 2006. Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides. Recent Patents Anti-Infect. Drug Disc. 1:201-207.
30. Mickels, N., C. McManus, J. Massaro, P. Friden, V. Braman, R. D'Agostino, F. Oppenheim, M. Warbington, S. Dibart, and T. Van Dyke. 2001. Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis. J. Clin. Periodontol. 28:404-410.
31. Nemoto, K., T. Kubo, M. Nomachi, T. Sano, T. Matsumoto, K. Hosoya, T. Hattori, and K. Kaya. 2007. Simple and effective 3D recognition of domoic acid using a molecularly imprinted polymer. J. Am. Chem. Soc. 129:13626-13632.
32. Ouellette, A. J., and J. C. Lualdi. 1990. A novel mouse gene family coding for cationic, cysteine-rich peptides. Regulation in small intestine and cells of myeloid origin. J. Biol. Chem. 265:9831-9837.
33. Raimondo, D., G. Andreotti, N. Saint, P. Amodeo, G. Renzone, M. Sanseverino, I. Zocchi, G. Molle, A. Motta, and A. Scaloni. 2005. A folding-dependent mechanism of antimicrobial peptide resistance to degradation unveiled by solution structure of distinctin. Proc. Natl. Acad. Sci. U. S. A. 102:6309-6314.
34. Reddy, K. V., R. D. Yedery, and C. Aranha. 2004. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 24:536-547.
35. Rozek, A., J. P. Powers, C. L. Friedrich, and R. E. Hancock. 2003. Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry 42:14130-14138.
36. Saarialho-Kere, U. K., E. C. Crouch, and W. C. Parks. 1995. Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J. Invest. Dermatol. 105:190-196.
37. Schmidtchen, A., I. M. Frick, E. Andersson, H. Tapper, and L. Björck. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46:157-168.
38. Scocchi, M., I. Zelezetsky, M. Benincasa, R. Gennaro, A. Mazzoli, and A. Tossi. 2005. Structural aspects and biological properties of the cathelicidin PMAP-36. FEBS J. 272:4398-4406.
39. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248.
40. Sieprawska-Lupa, M., P. Mydel, K. Krawczyk, K. Wójcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, J. Pohl, W. Shafer, F. McAleese, T. Foster, J. Travis, and J. Potempa. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48:4673-4679.
41. Steinberg, D. A., and R. I. Lehrer. 1997. Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. Methods Mol. Biol. 78:169-186.
42. Svenson, J., W. Stensen, B. O. Brandsdal, B. E. Haug, J. Monrad, and J. S. Svendsen. 2008. Antimicrobial peptides with stability toward tryptic degradation. Biochemistry 47:3777-3788.
43. Unger, T., Z. Oren, and Y. Shai. 2001. The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implication to their mode of action. Biochemistry 40:6388-6397.
44. Vanlaere, I., and C. Libert. 2009. Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin. Microbiol. Rev. 22:224-239.
45. Wakamatsu, K., A. Takeda, T. Tachi, and K. Matsuzaki. 2002. Dimer structure of magainin 2 bound to phospholipid vesicles. Biopolymers 64:314-327.
46. Werle, M., and A. Bernkop-Schnürch. 2006. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 30:351-367.
47. Werthén, M., M. Davoudi, A. Sonesson, D. P. Nitsche, M. Mörgelin, K. Blom, and A. Schmidtchen. 2004. Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. J. Antimicrob. Chemother. 54:772-779.
48. Yomogida, S., I. Nagaoka, and T. Yamashita. 1996. Purification of the 11-and 5-kDa antibacterial polypeptides from guinea pig neutrophils. Arch. Biochem. Biophys. 328:219-226.
49. Zhang, L., and T. J. Falla. 2009. Host defense peptides for use as potential therapeutics. Curr. Opin. Investig. Drugs 10:164-171.
50. Zhang, L., and T. J. Falla. 2006. Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. 7:653-663.